Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.40 |
| ▸ | CNR2 | P34972 | 4/20 | 0.37 |
| ▸ | CNR1 | P21554 | 2/20 | 0.37 |
| ▸ | PPARG | P37231 | 2/20 | 0.37 |
| ▸ | PPARD | Q03181 | 2/20 | 0.37 |
| ▸ | PPARA | Q07869 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4754373 | 1.00 | HCAR2 (0.40) | HCAR2CNR2CNR1PPARGPPARD | |
| SCHEMBL27771867 | 0.98 | HCAR2 (0.39) | HCAR2CNR2CNR1PPARGPPARD | |
| SCHEMBL27771869 | 0.98 | HCAR2 (0.39) | HCAR2CNR2CNR1PPARGPPARD | |
| SCHEMBL1173409 | 0.86 | HCAR2 (0.56) | HCAR2CNR2CNR1PPARGPPARD | |
| SCHEMBL1173410 | 0.86 | HCAR2 (0.56) | HCAR2CNR2CNR1PPARGPPARD | |
| SCHEMBL4866839 | 0.86 | — | — | |
| SCHEMBL4866847 | 0.86 | — | — | |
| SCHEMBL9573297 | 0.85 | HCAR2 (0.36) | HCAR2CNR2CNR1PPARGPPARD | |
| SCHEMBL9573292 | 0.85 | HCAR2 (0.36) | HCAR2CNR2CNR1PPARGPPARD | |
| SCHEMBL2911353 | 0.83 | HCAR2 (0.54) | HCAR2CA12AKR1B10CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008150609-A1 | ENERGY CURING BREATHABLE COATINGS | SUN CHEMICAL CORPORATION (US) | 2008-12-11 | — | — | WO | claimed |
| US-20080305349-A1 | Energy-curing breathable coatings (combined) | SUN CHEMICAL CORPORATION | 2008-12-11 | — | — | US | claimed |
| JP-4005258-A | — | — | None | — | — | JP | disclosed |
| US-20170305831-A1 | PREPARATION OF A SORBATE ESTER | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-10-26 | — | — | US | disclosed |
| EP-3209635-A1 | PREPARATION OF SORBATE ESTER | Dow Global Technologies LLC (US) | 2017-08-30 | — | — | EP | disclosed |
| WO-2008150609-A1 | ENERGY CURING BREATHABLE COATINGS | SUN CHEMICAL CORPORATION (US) | 2008-12-11 | — | — | WO | disclosed |
| US-20080305349-A1 | Energy-curing breathable coatings (combined) | SUN CHEMICAL CORPORATION | 2008-12-11 | — | — | US | disclosed |
| EP-0387654-B1 | Methods of producing alkylene glycol monosorbates | CHISSO CORP (JP) | 1994-10-12 | — | — | EP | disclosed |
| EP-0559239-A1 | Methods of producing and preserving alkylene glycol monosorbates | CHISSO CORPORATION (JP) | 1993-09-08 | — | — | EP | disclosed |
| JP-H045258-A | STABILIZATION OF ALKYLENE GLYCOL MONOSORBATE | CHISSO CORP | 1992-01-09 | — | — | JP | disclosed |
| US-5017720-A | Methods of producing and reserving alkylene glycol monosorbates | CHISSO CORPORATION (JP) | 1991-05-21 | — | — | US | disclosed |
| EP-0387654-A2 | Methods of producing alkylene glycol monosorbates | CHISSO CORPORATION (JP) | 1990-09-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170305831-A1 | PREPARATION OF A SORBATE ESTER | HAO2, SORBS1, HAO1 | HCAR2 227/4885CNR2 3815/4885CNR1 3509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.